期刊档案
Revista Portuguesa de Nefrologia e Hipertensao
ISSN 0872-0169 · eISSN 2976-0526 · Publicações Ciência e Vida · Portugal
Revista Portuguesa de Nefrologia e Hipertensao 钻石开放获取（无 APC），免版面费，投稿社区反馈审稿约 8 周，2025 年发文 0 篇。
研究范围
研究范围与定位
Revista Portuguesa de Nefrologia e Hipertensao 由 Publicações Ciência e Vida 出版。按 OpenAlex 近年发文统计，该刊主要发表 Dialysis and Renal Disease Management、Renal Diseases and Glomerulopathies、Chronic Kidney Disease and Diabetes 等主题的论文，这 3 个主题约占 40%，主导子领域为 Nephrology。（根据 OpenAlex 主题统计与中科院分区数据生成）
PKJ is an open access journal publishing articles on clinical or experimental studies of relevance to nephrology, pediatric nephrology, palliative nephrology, dialysis, renal transplantation and hypertension. Articles addressing health services, health care policy and socioeconomic issues of relevance to nephrology are welcome. Papers relating to basic immunology, physiology, genetics and epidemiology are accepted when kidney related. PKJ also publishes editorial matter relevant to nephrology.
摘自期刊官网 Aims & Scope
主编 Manuel Pestana出版商官网
编委会国家分布：未见中国大陆编委；主要国家 葡萄牙 39、西班牙 3、德国 1、巴西 1（共 44 位编委标注了国家） 编委会 ↗出版商官网 ·
主要研究主题 OpenAlex 近年发文统计，占比为近似值
- Dialysis and Renal Disease ManagementMedicine15.3%
- Renal Diseases and GlomerulopathiesMedicine13.9%
- Chronic Kidney Disease and DiabetesMedicine10.9%
- Renal Transplantation Outcomes and TreatmentsMedicine7.2%
- Vasculitis and related conditionsMedicine6.4%
- Acute Kidney Injury ResearchMedicine6.2%
- Central Venous Catheters and HemodialysisHealth Professions3.7%
- Systemic Lupus Erythematosus ResearchMedicine3.5%
分区与收录
学科分区与数据库收录
中科院期刊分区表
期刊分区表（ 2025年3月升级版）未收录
该期刊未被此版本分区表收录。
《新锐期刊分区表》（ 2026年3月发布）未收录
该期刊未被此版本分区表收录。
期刊分区表（ 2023年12月旧的升级版）未收录
该期刊未被此版本分区表收录。
数据库收录
DOAJLetPub
国际期刊预警名单：各版本均未列入LetPub
期刊官网自述收录
Web of ScienceSciELO出版商官网
期刊官网列出的收录清单，未与各数据库逐一核对；Web of Science 各子库以上方记录为准。
不同版本、大类与小类分别展示，不将不同评价口径合并为一个分区值；投稿与考核前请确认所在机构采用的版本。
指标
影响力指标与发文规模
影响力指标
- h-index
- 6OpenAlex ·
- i10-index
- 0OpenAlex ·
- 两年平均被引
- 0OpenAlex ·
- Gold OA 文章占比
- 0%LetPub ·
逐年发文量 OpenAlex 统计 · 累计 329 篇 · 当年数据不完整
| 年份 | 发文量 | 其中 OA | 被引 |
|---|---|---|---|
| 2026 | 0 | 0 | 21 |
| 2025 | 0 | 0 | 36 |
| 2024 | 0 | 0 | 24 |
| 2023 | 62 | 62 | 50 |
| 2022 | 72 | 72 | 35 |
| 2021 | 60 | 60 | 29 |
不同来源的统计口径与观测时间不同，页面保留各来源原值；“出版商公布”为期刊官网自述数据。
审稿与录用
审稿周期与录用情况
- 平均审稿速度（社区反馈）
- 8 WeeksLetPub ·
- 投稿到发表（期刊自报）
- 约 8 周DOAJ ·
- 评审方式
- 双盲同行评审DOAJ
社区反馈来自投稿者样本，置信度 0.5，不代表期刊承诺；“出版商公布”的时间节点定义以官网为准。
费用与开放获取
版面费与开放获取政策
钻石开放获取（无 APC）DOAJ
所有文章开放获取，且不向作者收取文章处理费。
| 来源 | 文章处理费 | 费用减免 | 许可证 | 观测时间 |
|---|---|---|---|---|
| DOAJ | 无文章处理费 | 无 | CC BY-NC | |
| LetPub | 无文章处理费 | 无 | — | |
| 出版商官网 | 无文章处理费 | — | — |
- APC 费用说明 ↗DOAJ
- 开放获取声明 ↗DOAJ
- 许可与版权 ↗DOAJ
费用以期刊官网为准；不同来源的观测时间可能不同，页面保留各来源原值，不做平均。
投稿要求
文章类型与投稿政策（官网）
投稿准备要点1 项，摘自作者指南
- 不接收
- preprint
接收的文章类型20 种，含篇幅限制
- case reportManuscripts are submitted to blind peer review by at least two anonymous reviewers, except where otherwise stated. Final acceptance or rejection rests with the …正文 ≤ 2,000 词
- case reports5) Case Reports;未说明篇幅
- current perspectives11) Current Perspectives.未说明篇幅
- editorialManuscripts are submitted to blind peer review by at least two anonymous reviewers, except where otherwise stated. Final acceptance or rejection rests with the …未说明篇幅
- images in nephrology6) Images in Nephrology;未说明篇幅
- letterManuscripts are submitted to blind peer review by at least two anonymous reviewers, except where otherwise stated. Final acceptance or rejection rests with the …未说明篇幅
- letters to the editorManuscripts are submitted to blind peer review by at least two anonymous reviewers, except where otherwise stated. Final acceptance or rejection rests with the …未说明篇幅
- meta-analysisManuscripts are submitted to blind peer review by at least two anonymous reviewers, except where otherwise stated. Final acceptance or rejection rests with the …未说明篇幅
- nephropathology quiz8) Nephropathology Quiz;未说明篇幅
- original articleManuscripts are submitted to blind peer review by at least two anonymous reviewers, except where otherwise stated. Final acceptance or rejection rests with the …未说明篇幅
- original articles4) Original Articles;未说明篇幅
- perspectiveManuscripts are submitted to blind peer review by at least two anonymous reviewers, except where otherwise stated. Final acceptance or rejection rests with the …正文 ≤ 1,250 词
- protocolManuscripts are submitted to blind peer review by at least two anonymous reviewers, except where otherwise stated. Final acceptance or rejection rests with the …未说明篇幅
- reviewManuscripts are submitted to blind peer review by at least two anonymous reviewers, except where otherwise stated. Final acceptance or rejection rests with the …未说明篇幅
- review articleManuscripts are submitted to blind peer review by at least two anonymous reviewers, except where otherwise stated. Final acceptance or rejection rests with the …未说明篇幅
- review articles2) Review Articles;未说明篇幅
- study protocols10) Study Protocols;未说明篇幅
- systematic reviewManuscripts are submitted to blind peer review by at least two anonymous reviewers, except where otherwise stated. Final acceptance or rejection rests with the …正文 ≤ 4,000 词
- systematic reviews and meta-analysis3) Systematic Reviews and Meta-analysis;未说明篇幅
- top article9) Top Article;未说明篇幅
官网政策摘录作者资格、利益冲突、数据可用性、出版伦理、许可与版权、开放获取、同行评审、查重、预印本、试验注册 / 报告规范
- 作者资格 6.10. Authorship and Responsabilities
作者伦理责任政策总体遵循ICMJE建议和COPE核心实践，PKJ可能使用软件检测抄袭，作者须遵守良好科学实践规则，包括不得同时向多个期刊投稿、所提交工作须为原创且未以任何形式或语言在其他地方发表。 模型中文摘要
6.10.1. Ethical Responsibilities of Authors PKJ policies generally follow those provided in ICMJE Recommendations https://www.icmje.org/recommendations, and the Core Practices of Committee on Publications Ethics (COPE) https://publicationethics.org . Important note: the PKJ may use software to screen for plagiarism. Authors must follow the rules of good scientific practice, which include: The manu…
原文 ↗出版商官网 ·- 利益冲突 6.10.11. Potential Conflicts of Interest for Authors
PKJ的利益冲突政策总体遵循ICMJE建议，作者必须披露所有可能被视为潜在利益冲突的关系；当与他人的财务或个人关系可能不当影响或偏颇行为时即存在利益冲突，无论个人是否认为该关系影响其科学判断。 模型中文摘要
PKJ conflict of interest (COI) policies generally follow those of the ICMJE Recommendations. Authors must disclose all relationships that could be viewed as a potential COI. A COI may exist when financial or personal relationships with other persons or organizations may inappropriately influence or bias actions. There is a potential for a COI whether or not an individual believes that a relationsh…
原文 ↗出版商官网 ·- 数据可用性 6.8. Data Sharing and Accessibility
每篇报告临床试验的稿件必须包含数据共享声明；PKJ目前除要求编辑可查阅数据外没有特定数据共享期望，要求仅是作者对其数据共享意向保持透明，声明应说明将共享的数据类型。 模型中文摘要
In recognition of the increased attention given to reproducibility of research findings, and to enhance opportunities for research collaboration, each manuscript reporting a clinical trial must include a data sharing statement. PKJ does not currently have a particular data sharing expectation (beyond the stipulation that data be available for editors’ inspection, as detailed in the Research and Pu…
原文 ↗出版商官网 ·- 出版伦理 8.3. Misconduct Handling Policy
PKJ严肃对待潜在学术不端指控，主编可能联系并与第三方（如作者所在机构和伦理委员会）共享稿件，也可能向COPE寻求建议并在COPE论坛讨论匿名案例；若怀疑研究未在适当伦理框架内进行，主编可拒稿并告知第三方。 模型中文摘要
PKJ takes seriously allegations of potential misconduct. In cases of suspected research or publication misconduct, it may be necessary for the Editor-in-chief to contact and share manuscripts with third parties, for example, author(s)’ institution(s) and ethics committee(s). PKJ may also seek advice from COPE and discuss anonymized cases in the COPE Forum. 8.3.1. Research Misconduct If there is su…
原文 ↗出版商官网 ·- 许可与版权 6.9. Copyright
PKJ文章采用知识共享署名-非商业许可（CC BY-NC），允许在正确引用原作且非商业用途的情况下以任何媒介使用、分发和复制；作者保留版权，授予PKJ出版许可并授予任何第三方自由使用文章的权利。 模型中文摘要
Articles in PKJ are licensed under a Creative Commons Attribution:Non-Commercial License (License CC BY-NC). The Creative Commons Attribution Non-Commercial License (CC BY NC) permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. Copyright in any article published by PKJ under the CC BY NC license is retained…
原文 ↗出版商官网 ·- 开放获取 3. Platinum Open Access
PKJ是白金开放获取期刊，不收取任何作者费用（APC），所有文章在出版后立即免费且永久在线获取。 模型中文摘要
PKJ is a platinum open access journal, and does not charge any author fees (APC - article processing charges). All articles published by PKJ are made freely and permanently accessible online immediately upon publication, without charges. Link to PKJ Agreement
原文 ↗出版商官网 ·- 同行评审 6.1. Peer Review
同行评审由相关领域的独立研究者评估稿件的原创性、有效性和重要性，以帮助主编决定是否发表；稿件须以清晰、简洁、直接的风格撰写，且不得已在其他地方发表或投稿；审稿人须保密，不得泄露稿件细节。 模型中文摘要
Peer-review is the system used to assess the quality of a manuscript before it is published. Independent researchers in the relevant research area assess submitted manuscripts for originality, validity and significance to help editor-in-chief to determine whether the manuscript should be published in the journal. Manuscripts should be written in a clear, concise, and direct style. In addition, the…
原文 ↗出版商官网 ·- 查重 8.3.4. Plagiarism
如发现抄袭，将遵循COPE的抄袭指南处理。 模型中文摘要
If plagiarism is identified, the COPE guidelines on plagiarism will be followed.
原文 ↗出版商官网 ·- 预印本 4.1. Preprint Policy
PKJ接受曾在预印本服务器上发表的文章并考虑对其进行同行评审；文章被接受后，作者须更新任何预出版版本并附上指向最终发表文章的链接。 模型中文摘要
PKJ accepts articles previously published on preprint servers. PKJ will consider for peer review, articles previously available as preprint. If the article is accepted for publication, authors are requested to update any pre-publication version with a link to the final published article.
原文 ↗出版商官网 ·- 试验注册 / 报告规范 6.5. Clinical Trial Registration
PKJ采用WHO的临床试验定义，即前瞻性地将人类参与者分配到一项或多项健康相关干预以评估健康结局的研究；健康干预是为、与或代表个人或人群实施的以评估、改善、维持、促进或修改健康、功能或健康状况的行为。 模型中文摘要
The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to ass…
原文 ↗出版商官网 ·
摘录来自期刊官网页面，仅保留原文片段；“模型摘要”由 Workers AI 生成并经原文校验，以官网为准。
基本信息
出版信息与官方入口
- 出版商
- Publicações Ciência e Vida
- 出版国家或地区
- Portugal
- 出版语言
- English
- ISSN
- 0872-0169
- 电子版 ISSN
- 2976-0526
- 学会 / 主办单位
- Portuguese Society of Nephrology
- 官网最新一期
- Volume 40, Issue 2（2026 年）
- 官方链接
- 期刊主页 ↗DOAJ
- 作者指南 ↗DOAJ
- Aims & Scope ↗LetPub
- APC 费用说明 ↗DOAJ
- 开放获取声明 ↗DOAJ
- 许可与版权 ↗DOAJ
- 评审流程 ↗DOAJ
- 编委会 ↗DOAJ
常见问题
关于 Revista Portuguesa de Nefrologia e Hipertensao 的常见问题
Revista Portuguesa de Nefrologia e Hipertensao 的审稿周期多长？
投稿社区反馈的平均审稿速度为约 8 周。文章统计只含被录用的稿件，出版商数据口径以官网为准，社区反馈来自投稿者样本，均不代表期刊承诺。
Revista Portuguesa de Nefrologia e Hipertensao 的编委会里有中国学者吗？
期刊官网编委会页面上标注了国家的 44 位编委中，没有中国大陆学者；人数最多的国家是 葡萄牙（39 位）、西班牙（3 位）、德国（1 位）。统计按编委会页面列出的机构国家计，仅供参考。
Revista Portuguesa de Nefrologia e Hipertensao 被哪些数据库收录？
据 LetPub 与 DOAJ 记录，Revista Portuguesa de Nefrologia e Hipertensao 被 DOAJ 收录。期刊官网自述还被 Web of Science、SciELO 收录，该清单未与各数据库逐一核对。
Revista Portuguesa de Nefrologia e Hipertensao 是开放获取期刊吗？版面费多少？
Revista Portuguesa de Nefrologia e Hipertensao 为钻石开放获取（无 APC）。不收取文章处理费。
来源与更新
本页事实来自 LetPub、OpenAlex、DOAJ、出版商官网；每个数字旁标注来源与观测日期，冲突数据保留各来源原值。LetPub 原始详情页：查看 ↗（2026-08-26 归档）。最近更新：。